Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Open-market sale Director sold 30,000 shares at $8.23 ($246,810)
  2. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chairman, CEO & President bought 10,000 shares at an average $6.86 ($68,565)
  19. 4 Open-market buy EVP-R&D & Chief Scien. Officer bought 3,000 shares at an average $6.87 ($20,605)
  20. 4 Open-market buy Exec VP Finance, CFO bought 1,000 shares at $6.87 ($6,868)

Page 15 of 28 · 560 filings